Imunon Inc investor relations material

Listen to the latest call from Imunon Inc

Imunon Inc., formerly Celsion Corporation, a clinical stage biotechnology company, focuses on the development of novel theragnostic technologies for cancer, including the use of radiolabeled DNA plasmids to treat cancer. Celsion has developed, among other, ThermoDox, a DNA plasmid with its proprietary heat-activated liposomal delivery technology, which is designed to improve the effectiveness of cancer immunotherapies such as vaccines and adoptive cell therapies. The company's customers are pharmaceutical and biotechnology companies, research institutions, hospitals and clinics.

Dig deeper into the Imunon Inc fundamentals on Quartr.